Common use of Common Interest Clause in Contracts

Common Interest. All information exchanged between the Parties regarding the prosecution and maintenance, and enforcement and defense, of the Eidos Patents, Joint Patents and Joint Invention Patents under this Article 9 will be deemed Confidential Information of the disclosing Party. In addition, the Parties acknowledge and agree that, with regard to such prosecution and maintenance, and enforcement and defense, the interests of the Parties as licensor and licensee are to obtain the strongest Patent protection possible, and as such, are aligned and are legal in nature. The Parties agree and acknowledge that they have not waived, and nothing in this Agreement constitutes a waiver of, any legal privilege concerning the Patent rights under this Article 9, including privilege under the common interest doctrine and similar or related doctrines. Notwithstanding anything to the contrary contained herein, to the extent a Party has a good faith belief that any information required to be disclosed by such Party to the other Party under this Article 9 is protected by attorney-client privilege or any other applicable legal privilege or immunity, such Party will not be required to disclose such information, and the Parties will in good faith cooperate to agree upon a procedure (including entering into a specific common interest agreement, disclosing such information on a “for counsel eyes only” basis or similar procedure) under which such information may be disclosed without waiving or breaching such privilege or immunity.

Common Interest. All information exchanged between the Parties regarding the prosecution and prosecution, maintenance, and enforcement and defense, defense of the Eidos Patents, Joint Patents and Joint Invention Patents under this Article ARTICLE 9 will be deemed to be Confidential Information of the disclosing Party. In addition, the Parties acknowledge and agree that, with regard to such prosecution and prosecution, maintenance, and enforcement and defense, the interests of the Parties as licensor collaborators are to, for their mutual benefit, obtain patent protection and licensee are to obtain the strongest Patent protection possibleplan patent defense against potential infringement activities by Third Parties, and as such, are aligned and are legal in nature. The Parties agree and acknowledge that they have not waived, and nothing in this Agreement constitutes a waiver of, any legal privilege concerning the Patent rights Patents under this Article ARTICLE 9, including privilege under the common interest doctrine and similar or related doctrines. Notwithstanding anything to the contrary contained hereinin this Agreement, to the extent a Party has a good faith belief that any information required to be disclosed by such Party to the other Party under this Article ARTICLE 9 is protected by attorney-client privilege or any other applicable legal privilege or immunity, such Party will shall not be required to disclose such information, information and the Parties will shall in good faith cooperate to agree upon a procedure (including without limitation entering into a specific common interest agreement, agreement or disclosing such information on a “for counsel eyes only” basis or similar procedure) under which such information may be disclosed without waiving or breaching such privilege or immunity.

Common Interest. All information exchanged between the Parties regarding the prosecution and prosecution, maintenance, and enforcement and defense, defense of the Eidos Patents, Joint Patents and Joint Invention Patents under this Article ARTICLE 9 will be deemed to be Confidential Information of the disclosing Party. In addition, the Parties acknowledge and agree that, with regard to such prosecution and prosecution, maintenance, and enforcement enforcement, and defense, the interests of the Parties as licensor collaborators are to, for their mutual benefit, obtain patent protection and licensee are to obtain the strongest Patent protection possibleplan patent defense against potential infringement activities by Third Parties, and as such, are aligned and are legal in nature. The Parties agree and acknowledge that they have not waived, and nothing in this Agreement constitutes a waiver of, any legal privilege concerning the Patent rights Patents under this Article ARTICLE 9, including privilege under the common interest doctrine and similar or related doctrines. Notwithstanding anything to the contrary contained hereinin this Agreement, to the extent a Party has a good faith belief that any information required to be disclosed by such Party to the other Party under this Article ARTICLE 9 is protected by attorney-client privilege or any other applicable legal privilege or immunity, such Party will shall not be required to disclose such information, information and the Parties will shall in good faith cooperate to agree upon a procedure (including entering into a specific common interest agreement, agreement or disclosing such information on a “for 254821559 v1 counsel eyes only” basis or similar procedure) under which such information may be disclosed without waiving or breaching such privilege or immunity.

Common Interest. All information exchanged between the Parties regarding the prosecution Prosecution and maintenanceMaintenance, and enforcement and defense, of the Eidos Patents, Joint Patents and Joint Invention Patents under this Article 9 ARTICLE 12 will be deemed Confidential Information of the disclosing Party. In addition, the Parties acknowledge and agree that, with regard to such prosecution Prosecution and maintenanceMaintenance, and enforcement and defense, the interests of the Parties as collaborators and licensor and licensee are to obtain the strongest Patent patent protection possible, and as such, are aligned and are legal in nature. The Parties agree and acknowledge that they have not waived, and nothing in this Agreement constitutes a waiver of, any legal privilege concerning the Patent rights Patents under this Article 9ARTICLE 12, including privilege under the common interest doctrine and similar or related doctrines. Notwithstanding anything to the contrary contained herein, to the extent a Party has a good faith belief that any information required to be disclosed by such Party to the other Party under this Article 9 ARTICLE 12 is protected by attorney-client privilege or any other applicable legal privilege or immunity, such Party will not be required to disclose such information, and the Parties will in good faith cooperate to agree upon a procedure (including entering into a specific common interest agreement, disclosing such information on a “for counsel eyes only” basis or similar procedure) under which such information may be disclosed without waiving or breaching such privilege or immunity.

Common Interest. All information exchanged between the Parties regarding the prosecution and prosecution, maintenance, and enforcement and defense, defense of the Eidos Patents, Joint Patents and Joint Invention Patents under this Article ARTICLE 9 will be deemed to be Confidential Information of the disclosing Party. In addition, the Parties acknowledge and agree that, with regard to such prosecution and prosecution, maintenance, and enforcement enforcement, and defense, the interests of the Parties as licensor collaborators are to, for their mutual benefit, obtain patent protection and licensee are to obtain the strongest Patent protection possibleplan patent defense against potential infringement activities by Third Parties, and as such, are aligned and are legal in nature. The Parties agree and acknowledge that they have not waived, and nothing in this Agreement constitutes a waiver of, any legal privilege concerning the Patent rights Patents under this Article ARTICLE 9, including privilege under the common interest doctrine and similar or related doctrines. Notwithstanding anything to the contrary contained hereinin this Agreement, to the extent a Party has a good faith belief that any information required to be disclosed by such Party to the other Party under this Article ARTICLE 9 is protected by attorney-client privilege or any other applicable legal privilege or immunity, such Party will shall not be required to disclose such information, information and the Parties will shall in good faith cooperate to agree upon a procedure (including entering into a specific common interest agreement, agreement or disclosing such information on a “for counsel eyes only” basis or similar procedure) under which such information may be disclosed without waiving or breaching such privilege or immunity.

Common Interest. All information exchanged between the Parties regarding the prosecution and prosecution, maintenance, and enforcement and defense, defense of the Eidos Patents, Joint Patents and Joint Invention Patents under this Article 9 7 will be deemed to be Confidential Information of the disclosing Party. In addition, the Parties acknowledge and agree that, with regard to such prosecution and prosecution, maintenance, and enforcement and defense, the interests of the Parties as licensor collaborators and Harpoon and licensee are to to, for their mutual benefit, obtain the strongest Patent patent protection possibleand plan patent defense against potential infringement activities by Third Parties, and as such, are aligned and are legal in nature. The Parties agree and acknowledge that they have not waived, and nothing in this Agreement constitutes a waiver of, any legal privilege concerning the Patent rights Patents under this Article 97, including privilege under the common interest doctrine and similar or related doctrines. Notwithstanding anything to the contrary contained hereinin this Agreement, to the extent a Party has a good faith belief that any information required to be disclosed by such Party to the other Party under this Article 9 7 is protected by attorney-client privilege or any other applicable legal privilege or immunity, such Party will shall not be required to disclose such information, information and the Parties will shall in good faith cooperate to agree upon a procedure (including which may include entering into a specific common interest agreement, disclosing such information on a “for counsel eyes only” basis or similar procedure) under which such information may be disclosed without waiving or breaching such privilege or immunity.